Gagnon Securities LLC Sells 10,465 Shares of Intuitive Surgical, Inc. $ISRG

Gagnon Securities LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.4% during the third quarter, Holdings Channel.com reports. The firm owned 43,359 shares of the medical equipment provider’s stock after selling 10,465 shares during the period. Intuitive Surgical accounts for about 3.9% of Gagnon Securities LLC’s portfolio, making the stock its 7th biggest position. Gagnon Securities LLC’s holdings in Intuitive Surgical were worth $19,391,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC grew its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC lifted its holdings in shares of Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares in the last quarter. Cooper Financial Group grew its position in Intuitive Surgical by 6.6% in the 2nd quarter. Cooper Financial Group now owns 1,332 shares of the medical equipment provider’s stock valued at $724,000 after purchasing an additional 83 shares during the period. Consolidated Portfolio Review Corp increased its stake in Intuitive Surgical by 43.6% during the 2nd quarter. Consolidated Portfolio Review Corp now owns 603 shares of the medical equipment provider’s stock valued at $328,000 after purchasing an additional 183 shares in the last quarter. Finally, Trilogy Capital Inc. bought a new stake in Intuitive Surgical during the 2nd quarter valued at $2,374,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Down 2.8%

ISRG stock opened at $507.55 on Friday. The firm has a market cap of $181.95 billion, a PE ratio of 64.33, a P/E/G ratio of 4.05 and a beta of 1.67. The business has a 50 day moving average of $559.78 and a 200-day moving average of $511.72. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the firm earned $2.21 earnings per share. The business’s revenue was up 18.8% on a year-over-year basis. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: FDA clearance expands the da Vinci 5 indication set into select advanced cardiac procedures — large addressable‑market implication and a long‑term revenue tail for systems and consumables. Read More.
• Positive Sentiment: TD Cowen initiated/raised coverage to a strong‑buy, which can attract institutional demand and support near‑term buying interest. Read More.
• Positive Sentiment: Major sell‑side support continues (Barclays reaffirmed buy) and HSBC issued a bullish price‑appreciation forecast — both reinforce positive analyst momentum around growth prospects. Read More. Read More.
• Positive Sentiment: Active managers (Polen Capital) are highlighting ISRG as a core growth holding, signaling conviction from long‑term growth investors. Read More.
• Neutral Sentiment: Analysts are split on valuation — some price‑target trims (e.g., Evercore ISI) coexist with higher targets from other firms; that creates mixed guidance for short‑term price direction. Read More.
• Neutral Sentiment: Coverage pieces questioning whether to “reassess” ISRG after recent share weakness may drive flows from momentum or value‑oriented investors, but they’re not direct catalysts. Read More.
• Negative Sentiment: Significant insider selling by director Gary S. Guthart (24,500 shares + 2,800 shares disclosed) — large, disclosed sales can trigger profit‑taking and amplify downward pressure on the stock near term. Read More.
• Negative Sentiment: EVP Myriam Curet sold 230 shares (smaller amount) — adds to the day’s insider activity and can increase negative sentiment despite being immaterial in size. Read More.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the sale, the executive vice president directly owned 5,758 shares in the company, valued at approximately $3,310,850. This represents a 37.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 75,557 shares of company stock valued at $42,000,903 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Evercore ISI reduced their price objective on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a report on Friday, January 23rd. Sanford C. Bernstein lifted their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. Piper Sandler reissued an “overweight” rating and set a $620.00 price objective (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. BTIG Research reissued a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Argus lifted their target price on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $620.41.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.